Biogen and Ionis Pharmaceuticals Report Nusinersen Meets Primary Endpoint at Interim Analysis of Phase 3 ENDEAR Study in Infantile-Onset Spinal Muscular Atrophy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SKA-B
10. PBA

Go back to Biogen and Ionis Pharmaceuticals Report Nusinersen Meets Primary Endpoint at Interim Analysis of Phase 3 ENDEAR Study in Infantile-Onset Spinal Muscular Atrophy
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 216.12 +6.38 (3.04%)
Previous Close $209.74    52 Week High $333.65 
Open $212.74    52 Week Low $223.02 
Day High $219.02    P/E 27.67 
Day Low $210.75    EPS $7.81 
Volume 1,155,166       

(NASDAQ: IONS) Delayed: 81.80 +2.61 (3.30%)
Previous Close $79.19    52 Week High $62.68 
Open $79.53    52 Week Low $19.59 
Day High $81.99    P/E N/A 
Day Low $79.11    EPS $0.00 
Volume 2,301,900